[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @RheumNow Dr. John Cush Dr. John Cush posts on X about $abbv, health, reduce, longterm the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::279184000/interactions)  - X Week XXXXX -XX% - X Month XXXXXX +23% - X Months XXXXXXX +24% - X Year XXXXXXX +31% ### Mentions: X [#](/creator/twitter::279184000/posts_active)  - X Month XX -XX% - X Months XXX +17% - X Year XXX +123% ### Followers: XXXXXX [#](/creator/twitter::279184000/followers)  - X Week XXXXXX +0.06% - X Month XXXXXX +0.24% - X Months XXXXXX +4.30% - X Year XXXXXX +7.80% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::279184000/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) [currencies](/list/currencies) [finance](/list/finance) **Social topic influence** [$abbv](/topic/$abbv) #49, [health](/topic/health), [reduce](/topic/reduce), [longterm](/topic/longterm), [the latest](/topic/the-latest), [what is](/topic/what-is), [ana](/topic/ana), [fomo](/topic/fomo), [countdown](/topic/countdown), [feb](/topic/feb) **Top accounts mentioned or mentioned by** [@drdavidliew](/creator/undefined) [@12](/creator/undefined) [@24](/creator/undefined) [@adelacastro222](/creator/undefined) [@baseline](/creator/undefined) [@3yrs](/creator/undefined) [@rwcs](/creator/undefined) [@ejdein1](/creator/undefined) [@ericdeinmd](/creator/undefined) [@doses](/creator/undefined) [@anishadua](/creator/undefined) [@rheummd](/creator/undefined) [@drceowen](/creator/undefined) [@drmaxyates1](/creator/undefined) [@richardpaconway](/creator/undefined) [@aurelierheumo](/creator/undefined) [@acrheum](/creator/undefined) [@mcp](/creator/undefined) [@eularorg](/creator/undefined) [@youtube](/creator/undefined) **Top assets mentioned** [AbbVie Inc (ABBV)](/topic/$abbv) ### Top Social Posts Top posts by engagements in the last XX hours "Partial vs Total Knee Replacement: Is One Superior Patients with osteoarthritis (OA) primarily affecting only one knee joint compartment did just as well with partial knee replacement (PKR) as with total arthroplasty after XX years in a randomized trial -- and maybe a little bit better" [X Link](https://x.com/RheumNow/status/1994904237319303460) 2025-11-29T23:00Z 24.9K followers, XXX engagements "Review of neonatal Fc receptor (FcRn) blockers being developed by J&J argenx & UCB showing utility in autoimmune dz as they reduce autoantibodies. FcRn inhibitor market may be worth USD XXX billion by 2035. Approved for myasthenia gravis & being developed in Sjgrens SLE AIHA etc" [X Link](https://x.com/RheumNow/status/1991250307750256721) 2025-11-19T21:00Z 24.9K followers, 1032 engagements "Two years of a JAKi in GCA 📊 Dr. Dua and Dr. Boone share their thoughts on the latest data from a Phase X trial with a JAKi in GCA including key long-term efficacy and safety outcomes. Sponsored by AbbVie Medical Affairs + Health Impact" [X Link](https://x.com/RheumNow/status/1995508244400185589) 2025-12-01T15:00Z 24.9K followers, XXX engagements "A JAKi in GCA: 2-year efficacy and safety results in a Phase X study Discover how continued treatment with a JAKi impacted disease remission and steroid use. Sponsored by AbbVie Medical Affairs + Health Impact" [X Link](https://x.com/RheumNow/status/1997003288365965689) 2025-12-05T18:01Z 24.9K followers, XXX engagements "NEW ONLINE ACR POSTER: 2-year efficacy and safety outcomes with a JAKi in patients with GCA Click to see the latest results from a Phase X trial presented at ACR 2025 sponsored by AbbVie Medical Affairs + Health Impact" [X Link](https://x.com/RheumNow/status/1998090245976281491) 2025-12-08T18:00Z 24.9K followers, XXX engagements "RHEUM Survey What is the Sensitivity of the ANA test" [X Link](https://x.com/RheumNow/status/1998795447587029406) 2025-12-10T16:42Z 24.9K followers, XXX engagements "The countdown is on Drs. Jack Cush & Artie Kavanaugh are previewing whats coming to RheumNow Live 2026 in Dallas (Feb 78) and you dont want FOMO on this one. ✅ Register now at 🔥Early bird pricing ends December XX Get the inside scoop on whats ahead and lock in your spot now" [X Link](https://x.com/RheumNow/status/1998920741899681963) 2025-12-11T01:00Z 24.9K followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@RheumNow Dr. John CushDr. John Cush posts on X about $abbv, health, reduce, longterm the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence stocks currencies finance
Social topic influence $abbv #49, health, reduce, longterm, the latest, what is, ana, fomo, countdown, feb
Top accounts mentioned or mentioned by @drdavidliew @12 @24 @adelacastro222 @baseline @3yrs @rwcs @ejdein1 @ericdeinmd @doses @anishadua @rheummd @drceowen @drmaxyates1 @richardpaconway @aurelierheumo @acrheum @mcp @eularorg @youtube
Top assets mentioned AbbVie Inc (ABBV)
Top posts by engagements in the last XX hours
"Partial vs Total Knee Replacement: Is One Superior Patients with osteoarthritis (OA) primarily affecting only one knee joint compartment did just as well with partial knee replacement (PKR) as with total arthroplasty after XX years in a randomized trial -- and maybe a little bit better"
X Link 2025-11-29T23:00Z 24.9K followers, XXX engagements
"Review of neonatal Fc receptor (FcRn) blockers being developed by J&J argenx & UCB showing utility in autoimmune dz as they reduce autoantibodies. FcRn inhibitor market may be worth USD XXX billion by 2035. Approved for myasthenia gravis & being developed in Sjgrens SLE AIHA etc"
X Link 2025-11-19T21:00Z 24.9K followers, 1032 engagements
"Two years of a JAKi in GCA 📊 Dr. Dua and Dr. Boone share their thoughts on the latest data from a Phase X trial with a JAKi in GCA including key long-term efficacy and safety outcomes. Sponsored by AbbVie Medical Affairs + Health Impact"
X Link 2025-12-01T15:00Z 24.9K followers, XXX engagements
"A JAKi in GCA: 2-year efficacy and safety results in a Phase X study Discover how continued treatment with a JAKi impacted disease remission and steroid use. Sponsored by AbbVie Medical Affairs + Health Impact"
X Link 2025-12-05T18:01Z 24.9K followers, XXX engagements
"NEW ONLINE ACR POSTER: 2-year efficacy and safety outcomes with a JAKi in patients with GCA Click to see the latest results from a Phase X trial presented at ACR 2025 sponsored by AbbVie Medical Affairs + Health Impact"
X Link 2025-12-08T18:00Z 24.9K followers, XXX engagements
"RHEUM Survey What is the Sensitivity of the ANA test"
X Link 2025-12-10T16:42Z 24.9K followers, XXX engagements
"The countdown is on Drs. Jack Cush & Artie Kavanaugh are previewing whats coming to RheumNow Live 2026 in Dallas (Feb 78) and you dont want FOMO on this one. ✅ Register now at 🔥Early bird pricing ends December XX Get the inside scoop on whats ahead and lock in your spot now"
X Link 2025-12-11T01:00Z 24.9K followers, XXX engagements
/creator/twitter::RheumNow